Abstract:GalNAc-T3 catalyzes initial glycosylation of mucin-type O-linked protein involved in proliferation, adhesion, and migration of tumor cells. This study was performed to explore the relationships of the expression of GalNAc-T3 in small peripheral lung adenocarcinoma, especially as an indicator of prognosis.A retrospective analysis of the patients with small peripheral lung lesions, including 106 adenocarcinoma and two precancerous lesions (atypical adenomatous hyperplasia and adenocarcinoma in situ) after complete surgical resection, was launched. Expression of GalNAc-T3 was examined using immunohistochemistry staining on primary tumor specimens, and the tumors were reclassified in light of the IASLC/ATS/ERS (International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society) adenocarcinoma classifications followed by grading and scoring. Moreover, reverse transcription polymerase chain reaction and Western blot were used to study the expression of GalNAc-T3 in vivo.The low expression of GalNAc-T3 was found in the cytoplasm of tumor cells in 56 of 108 patients (51.9%) and was associated with IASLC/ATS/ERS classification of high risk groups (P=0.007), high Sica score (P=0.036), poorly differentiated tumor (P=0.023), poor tumor-node-metastasis (TNM) stage (P=0.007), pleural invasion (P=0.007), and vascular invasion (P<0.001) by Pearson's chi-squared test, but not with sex, age, smoking status, concentration of carcinoembryonic antigen, and lymph node metastasis. In logistic regression analysis, low GalNAc-T3 expression was only correlated with high-ranking TNM stage (odds ratio [OR] =8.975, 95% confidence interval [CI]: 1.797-44.661), vascular invasion (OR =5.668, 95% CI: 1.827-17.578), and the higher risk grade (low risk grade: OR =0.141, 95% CI: 0.027-0.719; moderate risk grade: OR =0.122, 95% CI: 0.017-40.871). The low expression of the GalNAc-T3 usually in adenocarcinoma cell lines was compared with normal bronchial epithelium cell line. Based on the univariate and multivariate analysis, poor TNM stage (P<0.001), pleural invasion (hazard ratio [HR]: 7.958, P=0.021), vascular invasion (HR: 2.403, P=0.040), and low GalNAc-T3 expression (HR: 3.317, P=0.016) were shown to be independently associated with an unfavorable prognosis. However, IASLC/ATS/ERS classification of risk groups and Sica score (P=0.034 and P=0.032, respectively) was correlated with overall survival on Kaplan-Meier method but not Cox regression model.GalNAc-T3 expression was correlated with the IASLC/ATS/ERS classification and also associated with prognosis of patients with completely resected small (≤2 cm) peripheral lung adenocarcinoma.

3’-Sulfo-TF Antigen Determined by GAL3ST2/ST3GAL1 Is Essential for Antitumor Activity of Fungal Galectin AAL/AAGL

A Tandem Enzymatic Approach for Detecting and Imaging Tumor-Associated Thomsen-Friedenreich Antigen Disaccharide.

Structural Basis for the Tumor Cell Apoptosis-Inducing Activity of an Antitumor Lectin from the Edible Mushroom Agrocybe Aegerita.

Molecular Character of the Recombinant Antitumor Lectin from the Edible Mushroom Agrocybe Aegerita.

Integrated Stable Isotope Labeling by Amino Acids in Cell Culture (SILAC) and Isobaric Tags for Relative and Absolute Quantitation (itraq) Quantitative Proteomic Analysis Identifies Galectin-1 As a Potential Biomarker for Predicting Sorafenib Resistance in Liver Cancer*

Serum 3′-Sulfo-lea Indication of Gastric Cancer Metastasis

ST6GALNAC4 Promotes Hepatocellular Carcinogenesis by Inducing Abnormal Glycosylation.

Glycoproteomic Analysis of Tissues from Patients with Colon Cancer Using Lectin Microarrays and Nanolc-Ms/ms.

ST3GAL1 Promotes Malignant Phenotypes in Intrahepatic Cholangiocarcinoma

[Expression of Galectin 3 and Sambucus Nigra Agglutinin and Their Clinicopathological Significance in Benign and Malignant Lesions of Stomach].

The glycosyltransferase ST3GAL4 drives immune evasion in acute myeloid leukemia by synthesizing ligands for the glyco-immune checkpoint receptor Siglec-9

Antitumor effect of soluble l3-glucan as an immune stimulant

Cancer-associated Carbohydrate-Binding Protein Galectin-3 and Its Therapeutic Ligands

Role of a Disease-associated ST3Gal-4 in Non-small Cell Lung Cancer

Discovery of antitumor lectins from rainforest tree root transcriptomes

Correlation between the expression of Gal : 3-O-sulfotransferase-2 and metastasis potentials of cancer cells

Antitumor activity of the protein and small molecule component fractions from Agrocybe aegerita through enhancement of cytokine production

Expression and Prognostic Value of GalNAc-T3 in Patients with Completely Resected Small (&le;2 Cm) Peripheral Lung Adenocarcinoma after IASLC/ATS/ERS Classification

Evaluation of Water Soluble Β-D-glucan from Auricularia Auricular-Judae As Potential Anti-Tumor Agent

[Experimental study on A549 cell death mediated by xenoantigen α-gal in human serum]

ALG3 contributes to stemness and radioresistance through regulating glycosylation of TGF-β receptor II in breast cancer